Clinical Trial Update: PK/PD of Extended-infusion Meropenem, Piperacillin-tazobactam and Cefepime in the Early Phase of Septic Shock [Phase 3]

View source ↗

Summary

Phase 3 trial update reports pharmacokinetic/pharmacodynamic data for extended-infusion meropenem, piperacillin-tazobactam, and cefepime in the early phase of s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Septic Shock

Drugs mentioned

• Cefepime (cefepime)
• Meropenem (Meropenem)
• Piperacillin/tazobactam (Piperacillin/tazobactam)

Snippet

Sponsor: Centre Hospitalier Universitaire de Besancon | Conditions: Septic Shock | Phase 3 | Status: COMPLETED